Verastem Inc. diskutieren
Verastem Inc.
WKN: A3EHM3 / Symbol: VSTM / Name: Verastem / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
6,45 €
-5,30 %
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $13.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target raised by analysts at Mizuho from $7.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target raised by analysts at BTIG Research from $13.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target raised by analysts at Royal Bank of Canada from $13.00 to $16.00. They now have an "outperform" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target raised by analysts at B. Riley from $7.00 to $9.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Royal Bank of Canada from $16.00 to $14.00. They now have an "outperform" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target raised by analysts at Guggenheim from $13.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Mizuho from $9.00 to $8.00. They now have an "outperform" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target raised by analysts at HC Wainwright from $10.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Royal Bank Of Canada from $16.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target raised by analysts at Royal Bank Of Canada from $12.00 to $13.00. They now have an "outperform" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem (NASDAQ:VSTM) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Ratings data for VSTM provided by MarketBeat
Verastem (NASDAQ:VSTM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $20.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem (NASDAQ:VSTM) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for VSTM provided by MarketBeat
Neueste Beiträge
HC_Wainwright in InflaRx NV diskutieren